The Patent Finder

Myrexis, Inc.

Also on record
Records under this name other than the patents Myrexis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Myrexis, Inc.

PatentTitleStatus Expires Confidence
US 7,595,401Therapeutic Compounds and Their Use in Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,476,285Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,653,139Drug substance preparations, pharmaceutical compositions and dosage forms
Formerly held
Lapsed on the fee record
Ended Feb 18, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2026From the USPTO record
US 8,318,425Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
Term ended
Term ended Sep 11, 2024 · From the USPTO record
Term endedTerm ended Sep 11, 2024From the USPTO record
US 9,034,871Compounds for Alzheimer's disease
Formerly held
Lapsed on the fee record
Ended May 19, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 19, 2023From the USPTO record
US 8,912,184Therapeutic and diagnostic methods
Formerly held
Lapsed on the fee record
Ended Dec 16, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 16, 2022From the USPTO record
US 7,714,022Pyrrole derivatives as therapeutic compounds
Formerly held
Lapsed on the fee record
Ended May 11, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 11, 2022From the USPTO record
US 7,678,823Compounds for alzheimer's disease
Formerly held
Lapsed on the fee record
Ended Mar 16, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 16, 2022From the USPTO record
US 7,618,9754-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
Lapsed on the fee record
Ended Nov 17, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 17, 2021From the USPTO record
US 8,309,562Compounds and therapeutical use thereof
Lapsed on the fee record
Ended Nov 13, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 13, 2020From the USPTO record
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited